News, markets, and regulation in Europe, Asia, and South America.
September 9, 2009
By:Sarah Houlton
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?
 |
July 8, 2009
By:Sarah Houlton
UK Health Institute leaves guidance unchanged in case against Eisai and Pfizer; more research on NICE methodology needed.
|
June 17, 2009
Pharma is wrestling to understand the emerging markets will be the engine of growth for future sales.
|
April 1, 2009
A new report by the Royal College of Physicians breaks down the reasons why patients are disillusioned about access to medicines, and documents a steady growth in the lack of trust between industry and the NHS. More importantly, it gives recommendations on how to solve the problems.
|
February 1, 2009
By:Sarah Houlton
EC proposal loosens restrictions on drug packaging and information dissemination.
|
December 1, 2008
By:Sarah Houlton
The new EU directive looks to reduce, refine, and eventually replace animal testing
|
November 1, 2008
By:Sarah Houlton
In Europe, it's different strokes for different folks at the top regulatory agencies
|
October 1, 2008
By:Sarah Houlton
Tensions mount as stakeholders in the UK health industry attempt to work out drug cost problems
|
September 1, 2008
By:Sarah Houlton
In order to take a big step forward, GSK looks to employ smaller licensing deals and business units
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
Applying E-Commerce to Support Discovery and Development of Medicines: Key Lessons and Learnings Tuesday, December 15 @ 11:00 a.m. ET
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?